Profound Medical Corp. (PROF)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
PROF price, last 12 months
Key stats
- Previous close
- $5.60
- Open
- $5.71
- Day range
- $5.61 – $5.86
- 52-week range
- $4.80 – $8.95
- Volume
- 259.8K
- Avg volume (20 days)
- 126.8K
- Market cap
- $210.5M
Performance
Technicals and fundamentals
About Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $210.5M